SciSparc Ltd. (NASDAQ:SPRC) began trading on the NASDAQ last month. It is a clinical stage pharmaceutical company with multiple catalysts. It has clinical trials set this year for its proprietary drug candidates. This Tel Aviv-based Company has a full portfolio of patented treatments and therapies focused on the central nervous system. It applies unique technologies… Continue reading SciSparc Ltd. (NASDAQ:SPRC) Uplists To NASDAQ, Full Pipeline Of Clinical Trials Set For 2022
May 3, 2024
Breaking News
- 4 Stocks To Watch In The $1.8 Trillion Race To Net Zero
- Does VivoPower International (NASDAQ:VVPR) Still Have More Upside?
- 4 Stocks with Exposure to the Growing Asian and Middle Eastern EV Markets
- 4 Stocks That Will Benefit From The Green Energy Revolution
- Calibre Mining Corp. (TSX: CXB) Capitalizing on Gold’s Surge
- Diamonds of Tomorrow: Adamas One Corp. (NASDAQ: JEWL) and the Lab-Grown Evolution
- New Partnerships Could Propel American Aires Inc. (CSE: WIFI) (OTC: AAIRF) to New Heights
- Revolutionizing Cinema: SportsQuest and Huayi Cinemas Merger Sparks Excitement
- American Aires Inc. (CSE:WIFI; OTC Pink:AAIRF) Proprietary Solution Against EMF Radiation Could Unlock Significant Shareholder Value
- 4 Stocks Poised To Pop With The AI Surge